Boston Scientific Inventory step-up amortization decreased by 60.0% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 97.5%, from $81.00M to $2.00M. Over 4 years (FY 2021 to FY 2025), Inventory step-up amortization shows an upward trend with a 40.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate recent significant acquisitions, which temporarily depress reported margins.
This is the non-cash expense related to the fair value adjustment of acquired inventory at the time of an acquisition. I...
Standard for companies with high M&A activity; usually transitory in nature.
operating_inventory_step_up_amortization| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $7.00M | $19.00M | $17.00M | $8.00M | $7.00M | $0.00 | $0.00 | $3.00M | $3.00M | $0.00 | $0.00 | $0.00 | $0.00 | $51.00M | $81.00M | $37.00M | $9.00M | $5.00M | $2.00M |
| QoQ Change | — | — | +171.4% | -10.5% | -52.9% | -12.5% | -100.0% | — | — | +0.0% | -100.0% | — | — | — | — | +58.8% | -54.3% | -75.7% | -44.4% | -60.0% |
| YoY Change | — | — | — | — | — | +0.0% | -100.0% | -100.0% | -62.5% | -57.1% | — | — | -100.0% | -100.0% | — | — | — | — | -90.2% | -97.5% |